Patents by Inventor Irene Papanicolaou

Irene Papanicolaou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110064819
    Abstract: The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles using Hip agents. Also provided are compositions comprising particulate carriers obtainable by such methods and uses of such compositions in treatment.
    Type: Application
    Filed: May 5, 2009
    Publication date: March 17, 2011
    Inventors: Andrew Beaton, Ian Richard Catchpole, Gerald Wayne Gough, Irene Papanicolaou
  • Publication number: 20110064821
    Abstract: The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles. Also provided are methods of delivery of proteins across the blood brain barrier in nanoparticles, and uses of such compositions in treatment.
    Type: Application
    Filed: May 5, 2009
    Publication date: March 17, 2011
    Inventors: Ian Richard Catchpole, Gerald Wayne Gough, Irene Papanicolaou
  • Publication number: 20110059142
    Abstract: The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles using Hip agents. Also provided are compositions comprising particulate carriers obtainable by such methods and uses of such compositions in treatment.
    Type: Application
    Filed: May 5, 2009
    Publication date: March 10, 2011
    Inventor: Irene Papanicolaou
  • Publication number: 20110059167
    Abstract: The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles using Hip agents. Also provided are compositions comprising particulate carriers obtainable by such methods and uses of such compositions in treatment.
    Type: Application
    Filed: May 5, 2009
    Publication date: March 10, 2011
    Inventors: Mehmet Fidanboylu, Irene Papanicolaou
  • Publication number: 20110045027
    Abstract: The present invention provides a novel adjuvant for polynucleotide vaccines, and in particular the present invention provides immunogenic compositions comprising a polynucleotide encoding an antigen capable of eliciting an immune response and an adjuvant comprising an immunostimulatory quantity of a gemini surfactant, or a derivative thereof.
    Type: Application
    Filed: June 20, 2006
    Publication date: February 24, 2011
    Applicant: Glaxo Group Limited
    Inventors: Ian Richard Catchpole, Irene Papanicolaou